The global central venous catheter market is poised for significant growth, with its valuation expected to exceed USD 5,314.5 million by 2033, rising from USD 3,238.1 million in 2023. This expansion represents a 5.1% compound annual growth rate (CAGR) during the forecast period, underscoring the increasing demand for innovative and life-saving medical devices.
One of the key drivers of this market’s growth is the emergence of “smart” central venous catheters, which integrate modern technology with traditional vascular access tools. Equipped with sensors, microprocessors, and real-time communication capabilities, these advanced devices monitor both catheter function and patient status, greatly enhancing safety. By identifying potential issues such as malpositioning or catheter occlusion, smart catheters help to prevent complications like catheter-related bloodstream infections (CRBSIs), a major cause of hospital-acquired infections. As patient safety and infection prevention become top priorities in healthcare settings, the demand for these cutting-edge devices is surging.
Additionally, the rising awareness of parenteral nutrition therapy is propelling the need for central venous catheters. Parenteral nutrition, the intravenous delivery of essential nutrients, is critical for patients unable to receive adequate nutrition through oral or enteral means. This therapy is commonly used for individuals with severe gastrointestinal conditions, cancer patients undergoing treatment, and post-surgery patients. The growing emphasis on proper nutrition for recovery and overall health is further driving the adoption of central venous catheters in hospitals and healthcare settings.
Key Insights from the Central Venous Catheter Market Report:
- The market was valued at USD 2,446.9 million in 2018, with a growth of 4.7% CAGR from 2018 to 2022.
- In 2022, the market size reached USD 3,074.7 million.
- The non-anti-microbial catheter segment accounted for 75.7% of market shares in 2022.
- The double lumen segment dominated with a 63.6% market share in 2022.
- Hospitals emerged as a key end-user segment, holding 60.3% of the market in 2022.
- The United Kingdom’s market is set to develop at a robust 9.0% CAGR through 2033.
- Germany is projected to grow at a 3.3% CAGR, while Australia’s market is expected to thrive at 5.1% CAGR through 2033.
As the central venous catheter industry continues to innovate and meet the growing demands of patient care, it is well-positioned to expand further, offering improved patient outcomes and reducing the risks of complications.
Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!
Recent Developments Observed by FMI:
- Coloplast unveiled a novel catheter in the United States in January 2023. The SpeediCath Flex Set catheter is intended for use by those with bladders and urine problems. Triple Action Coating Technology is a feature on all SpeediCath catheters designed to reduce the risk of urethral damage and urinary tract infections (UTIs) for patients with spinal cord injuries (SCI).
- Braun Medical Inc. (B. Braun), a pioneer in infusion therapy, announced the launch of its new Introcan Safety 2 IV Catheter with one-time blood control in July 2022. The Introcan Safety 2 IV Catheter, the newest invention from B. Braun, makes IV access safer for the clinician by reducing the risk of blood exposure and needlestick accidents.
Key Players in the Central Venous Catheter Market:
- Angio Dynamics
- C.R. Bard
- Teleflex Incorporated
- B. Braun Melsungen AG
- Kimal Healthcare
- Come B.V.
- Medtronic Plc
- Smiths Medical
- Vygon (UK) Ltd.
- Becton, Dickinson, and Company
- Argon Medical Devices Inc.
- Boston Scientific Corporation
- Cook Medical Incorporated
- Medical Components Inc.
- Fresenius Kabi AG
Central Venous Catheter Market Segmentation:
By Product:
- Dialysis Catheters
- Acute Hemodialysis Catheter
- Chronic Hemodialysis Catheter
- Peritoneal Dialysis Catheter
- PICC Catheters
- Implantable Port
- CVC Catheters
- Tunneled Catheters
- Non-tunneled Catheters
By Property:
- Anti-microbial Catheter
- Non-Anti-Microbial Catheter
By Design:
- Single Lumen
- Double Lumen
- Multiple Lumen
By End-user:
- Hospitals
- Ambulatory Surgical Centers
- Dialysis Centers
- Specialty Clinics
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube